Evidence map›Paper›PMID 31936857›Full record

ArticleJournal of clinical medicine2020

Jejunal Insulin Signalling Is Increased in Morbidly Obese Subjects with High Insulin Resistance and Is Regulated by Insulin and Leptin.

Carolina Gutierrez-Repiso, Ailec Ho-Plagaro, Concepción Santiago-Fernandez, Sara Garcia-Serrano, Francisca Rodríguez-Pacheco, Sergio Valdes, Lourdes Garrido-Sanchez, Cristina Rodríguez-Díaz, Carlos López-Gómez, Francisco J Moreno-Ruiz and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Carolina Gutierrez-RepisoInstituto de Investigación Biomédica de Málaga-IBIMA, 29009 Málaga, Spain.
Ailec Ho-PlagaroInstituto de Investigación Biomédica de Málaga-IBIMA, 29009 Málaga, Spain.
Concepción Santiago-FernandezInstituto de Investigación Biomédica de Málaga-IBIMA, 29009 Málaga, Spain.
Sara Garcia-SerranoInstituto de Investigación Biomédica de Málaga-IBIMA, 29009 Málaga, Spain.
Francisca Rodríguez-PachecoInstituto de Investigación Biomédica de Málaga-IBIMA, 29009 Málaga, Spain.
Sergio ValdesInstituto de Investigación Biomédica de Málaga-IBIMA, 29009 Málaga, Spain.
Lourdes Garrido-SanchezInstituto de Investigación Biomédica de Málaga-IBIMA, 29009 Málaga, Spain.
Cristina Rodríguez-DíazInstituto de Investigación Biomédica de Málaga-IBIMA, 29009 Málaga, Spain.
Carlos López-GómezInstituto de Investigación Biomédica de Málaga-IBIMA, 29009 Málaga, Spain.
Francisco J Moreno-RuizUnidad de Gestión Clínica de Cirugía General, Digestiva y Trasplantes, Hospital Regional Universitario, Málaga 29009, Spain.
Guillermo Alcain-MartinezInstituto de Investigación Biomédica de Málaga-IBIMA, 29009 Málaga, Spain.
Amandine Gautier-SteinInstitut National de la Santé et de la Recherche Médicale, U1213, F-69008 Lyon, France.
Gilles MithieuxInstitut National de la Santé et de la Recherche Médicale, U1213, F-69008 Lyon, France.
Eduardo Garcia-FuentesInstituto de Investigación Biomédica de Málaga-IBIMA, 29009 Málaga, Spain.
Hospital Clínico Universitario Virgen de la Victoria · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESUniversité Claude Bernard Lyon 1 · FRCentro de Investigación Biomédica en Red · ESHospital Regional Universitario de Málaga · ES

Funding

Instituto de Salud Carlos III PI12/00338
6 · The paper itself

Abstract

Little is known about the jejunal insulin signalling pathways in insulin resistance/diabetes states and their possible regulation by insulin/leptin. We study in jejunum the relation between insulin signalling and insulin resistance in morbidly obese subjects with low (MO-low-IR) or with high insulin resistance (MO-high-IR), and with type 2 diabetes treated with metformin (MO-metf-T2DM)), and the effect of insulin/leptin on intestinal epithelial cells (IEC). Insulin receptor substrate-1 (IRS1) and the catalytic p110β subunit (p110β) of phosphatidylinositol 3-kinase (PI3K) were higher in MO-high-IR than in MO-low-IR. The regulatory p85α subunit of PI3K (p85α)/p110β ratio was lower in MO-high-IR and MO-metf-T2DM than in MO-low-IR. Akt-phosphorylation in Ser473 was reduced in MO-high-IR compared with MO-low-IR. IRS1 and p110-β were associated with insulin and leptin levels. The improvement of body mass index (BMI) and HOMA-IR (homeostasis model assessment of insulin resistance index) after bariatric surgery was associated with a higher IRS1 and a lower p85α/p110β ratio. IEC (intestinal epithelial cells) incubation with a high glucose + insulin dose produced an increase of p85α and p110β. High dose of leptin produced an increase of IRS1, p85α and p110β. In conclusion, despite the existence of insulin resistance, the jejunal expression of genes involved in insulin signalling was increased in MO-high-IR. Their expressions were regulated mainly by leptin. IRS1 and p85α/p110β ratio was associated with the evolution of insulin resistance after bariatric surgery.

Indexed as

insulin resistancejejunumleptinmorbid obesity

Identifiers

PMID31936857
PMCPMC7019979
OpenAlexW3000262740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.